News

ADHD & Autism

As a practice, we are committed to supporting patients with neurodevelopmental conditions, both children and adults.

This page is for patients who are concerned they may have ADHD or Autism and are considering a referral. It explains:

  • The NHS referral process
  • The Right to Choose pathway
  • What happens if you use a private provider
  • How prescribing and shared care agreements work

⚠️ Please note: NHS resources are limited and waiting times for assessments are very long.

Attention Deficit Hyperactivity Disorder (ADHD) can affect many aspects of life including education, work, and relationships.

  • GPs cannot diagnose ADHD. A referral to a specialist service is needed.
  • If diagnosed, a specialist may offer medication. These medicines are tightly regulated and require careful monitoring.
  • GPs can only prescribe ADHD medication when there is a valid Shared Care Agreement in place with an NHS specialist team.

ADHD Referrals for Children

  • Pre-school children: Referral is discussed with the child’s Health Visitor or Early Years Setting. Services for Young Children – Hampshire County Council
  • School-age children: Referral is made by the school.
  • Home-schooled children: Referral can be made by the GP.

Supporting evidence is required for all referrals.

If the NHS Mental Health Team confirms a diagnosis, they may start treatment and, when stable, request a Shared Care Agreement so that your GP can continue prescribing safely.


ADHD Referrals for Adults (18+)

Demand for adult ADHD services is very high.

  • The Hampshire & Isle of Wight ICB has commissioned several providers who hold an NHS Standard Contract.
  • If diagnosed, treatment may be started by the provider and, once stable, transferred to your GP only if an NHS Shared Care Agreement is in place.
  • We ask that patients complete a questionnaire when they first contact us. This helps us to prepare your referral.

Right to Choose (RTC)

Under NHS legislation, patients can choose to be referred to any provider in England that holds an NHS Standard Contract.

👉 See available providers here: ADHD UK – Right to Choose

Important considerations:

  • Many RTC services offer diagnosis but not medication prescribing. If you choose a provider that includes medication initiation and titration and wish for it to be shared through your GP, a request will be sent and at the GP discretion this will either be accepted/rejected.
  • Some local NHS services may not accept assessments carried out by RTC providers, which could mean repeating the assessment.
  • If the provider chosen does not hold an NHS contract with Hampshire & IOW ICB, due diligence checks will need to be completed first — this may delay your referral.

Private Providers

You may choose to pay privately for an ADHD/Autism assessment and any medication that is initiated by a specialist in that service.

  • Prescribing and monitoring of medication must remain with the private provider.
  • We do not accept shared care agreements with private providers.
  • If you later wish to transfer to NHS care, you will need a new NHS referral and assessment before treatment can be considered.

⚠️ Please note: GPs are under no obligation to enter into a shared care agreement, even if requested.


Next Steps if You Want a Referral

  1. Decide your pathway:
    • NHS referral
    • Right to Choose
    • Private assessment (all care remains private)
  2. Let us know:
    • Contact us via online consultation, phone, or at reception to request an ADHD/Autism referral.
  3. Review your options:
  4. Complete the paperwork:
    • We will send you a questionnaire which will include several screening questions. Alternatively you can complete the questionnaire via this link ADHD Autism Qs Website
  5. Confirm your choice:
    • Tell us which pathway/provider you want to pursue and provide any forms that come with that provider. We will not continue a referral through a provider without the necessary forms being completed by the patient/carer.
    • We will then submit your referral.

Key Points to Remember

  • NHS ADHD and Autism referrals have very long waiting lists. We understand you will be keen to progress with any referral quickly once you have contacted us. We ask that you provide us with all the necessary information at the start to prevent delays.
  • Choosing RTC does not guarantee shared care or prescribing by your GP.
  • Private assessments remain private unless re-validated by the NHS.
  • GPs can only prescribe under a Shared Care Agreement with an NHS specialist.
  • ⚠️ Important Notice about Referrals

We understand that seeking an ADHD or Autism referral can feel urgent and frustrating. While patients do have a legal right to request a referral under NHS legislation, this does not mean an instant referral can be made.

    • Referrals take time to process. At our practice, this currently takes around 60 days due to the very high volume of requests (over 40 each month).
    • We must ensure that all referrals are completed safely, with the right forms and supporting evidence.
    • The Right to Choose pathway still involves long waiting times once the referral has been sent.

👉 Please be assured: once your request is logged, you will not lose your place. We will process referrals as quickly as we can, but we cannot provide same-day or immediate turnaround and we ask that you only contact us to chase the referral once we have hit the 60 day period since your request.


✅ This page aims to save you time and help you make an informed decision about the best referral option for you or your child.


Published on 18th Nov 2025

GLP-1 Injectables

GLP-1 medications, such as Semaglutide (Wegovy) and Tirzepatide (Mounjaro), are injectable treatments used for weight management and…. this then will have a link to enable the visitor to click on it and read the full information.

For Patients: Important Information About GLP-1 Injectable Medications

GLP-1 medications, such as Semaglutide (Wegovy) and Tirzepatide (Mounjaro), are injectable treatments used for weight management and diabetes control. These drugs work by slowing digestion, reducing appetite, and helping regulate blood sugar.

Prescribing Status

Currently, GLP-1 prescribing is not commissioned in all areas, and our practice is not commissioned to prescribe these medications. This means we are unable to provide GLP-1 treatments unless a specific contract or service agreement is in place.

For more information, you can refer to the official guidance from Wessex LMCs:
wessexlmcs.com/guidance/injectable-weight-loss-drugs

Important Information for Women Taking GLP-1 Injectable Medications

GLP-1 drugs can slow down digestion and affect the absorption of oral medications, including:

Hormone Replacement Therapy (HRT)

Oral contraceptives (the pill)

This may reduce how well these hormonal treatments work, leading to:

Increased risk of unintended pregnancy if using oral contraceptives.

Changes in hormone levels affecting HRT, potentially causing symptoms like irregular bleeding.

Recommendations for Women

Use additional or alternative contraception methods (e.g., condoms, IUDs) while taking GLP-1 medications.

Inform your healthcare provider if you are on HRT so your treatment can be reviewed and adjusted if needed.

Report any unusual symptoms such as breakthrough bleeding or hormonal changes promptly.

If you have questions or concerns about how GLP-1 treatments may affect your hormonal therapy, please contact us or your healthcare provider for advice.


Published on 18th Nov 2025

FLU & COVID

Please contact the surgery for your Influenza and/or COVID vaccinations.. we still have appointments available.


Published on 18th Nov 2025

Love Your Lungs Week

Poster with text: Do you know the signs of lung cancer? Come and talk to us during Love Your Lungs Week. We will be at the main entrance of each of these hospitals:  Monday 23 June Basingstoke and North Hampshire Hospital 9am-1pm Tuesday 24 June Southampton General Hospital 9am-1pm Thursday 26 June Queen Alexandra Hospital Portsmouth 9am-1pm

Find out more


Published on 10th Jun 2025

Page last reviewed: 18 November 2025
Page created: 03 May 2022